Publications:

---

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer.

Frontiers In Immunology

Aparicio, Belén B; Repáraz, David D; Ruiz, Marta M; Llopiz, Diana D; Silva, Leyre L; Vercher, Enric E; Theunissen, Patrick P; Tamayo, Ibon I; Smerdou, Cristian C; Igea, Ana A; Santisteban, Marta M; Gónzalez-Deza, Cristina C; Lasarte, Juan J JJ; Hervás-Stubbs, Sandra S; Sarobe, Pablo P

Publication Date: 2022

Variant appearance in text: HER2: G309A

PubMed Link: 36405725

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications

Boström, Martin M; Larsson, Erik E

Publication Date: 2022-11-17

Variant appearance in text: ERBB2: G309A

PubMed Link: 36396655

Variant Present in the following documents:

• 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1

View BVdb publication page

---

Improving prediction of response to neoadjuvant treatment in patients with breast cancer by combining liquid biopsies with multiparametric MRI: protocol of the LIMA study - a multicentre prospective observational cohort study.

Bmj Open

Janssen, Liselore M LM; Suelmann, Britt B M BBM; Elias, Sjoerd G SG; Janse, Markus H A MHA; van Diest, Paul J PJ; van der Wall, Elsken E; Gilhuijs, Kenneth G A KGA

Publication Date: 2022-09-20

Variant appearance in text: ERBB2: G309A

PubMed Link: 36127090

Variant Present in the following documents:

• bmjopen-2022-061334supp001.pdf
• bmjopen-2022-061334.reviewer_comments.pdf

View BVdb publication page

---

Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.

Nature Communications

Havugimana, Pierre C PC; Goel, Raghuveera Kumar RK; Phanse, Sadhna S; Youssef, Ahmed A; Padhorny, Dzmitry D; Kotelnikov, Sergei S; Kozakov, Dima D; Emili, Andrew A

Publication Date: 2022-07-13

Variant appearance in text: ERBB2: 926G>C; Gly309Ala

PubMed Link: 35831314

Variant Present in the following documents:

• 41467_2022_31809_MOESM8_ESM.xlsx, sheet 3

View BVdb publication page

---

Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects.

Cancer Research

Ishiyama, Noboru N; O'Connor, Matthew M; Salomatov, Andrei A; Romashko, Darlene D; Thakur, Shalabh S; Mentes, Ahmet A; Hopkins, Julia F JF; Frampton, Garrett M GM; Albacker, Lee A LA; Kohlmann, Anna A; Roberts, Christopher C; Buck, Elizabeth E

Publication Date: 2022-05-03

Variant appearance in text: HER2: G309A

PubMed Link: 35503682

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows.

Bmc Medical Genomics

Sobahy, Turki M TM; Tashkandi, Ghassan G; Bahussain, Donya D; Al-Harbi, Raneem R

Publication Date: 2022-04-25

Variant appearance in text: ERBB2: 926G>C

PubMed Link: 35468810

Variant Present in the following documents:

• 12920_2022_1235_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

---

Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling.

Nature Communications

Wu, Lucia Ruojia LR; Dai, Peng P; Wang, Michael Xiangjiang MX; Chen, Sherry Xi SX; Cohen, Evan N EN; Jayachandran, Gitanjali G; Zhang, Jinny Xuemeng JX; Serrano, Angela V AV; Xie, Nina Guanyi NG; Ueno, Naoto T NT; Reuben, James M JM; Barcenas, Carlos H CH; Zhang, David Yu DY

Publication Date: 2022-04-04

Variant appearance in text: ERBB2: G309A

PubMed Link: 35379811

Variant Present in the following documents:

• 41467_2022_29487_MOESM4_ESM.xlsx, sheet 3
• 41467_2022_29487_MOESM4_ESM.xlsx, sheet 2

View BVdb publication page

---

Systematic review and meta-analysis of genomic alterations in acral melanoma.

Pigment Cell & Melanoma Research

Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL

Publication Date: 2022-05

Variant appearance in text: ERBB2: G309A

PubMed Link: 35229492

Variant Present in the following documents:

• PCMR-35-369-s003.xlsx, sheet 12

View BVdb publication page

---

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer

Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J

Publication Date: 2022-02

Variant appearance in text: ERBB2: Gly309Ala

PubMed Link: 35221333

Variant Present in the following documents:

• 43018_2022_332_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

---

A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.

Genome Research

Chen, Siwei S; Liu, Yuan Y; Zhang, Yingying Y; Wierbowski, Shayne D SD; Lipkin, Steven M SM; Wei, Xiaomu X; Yu, Haiyuan H

Publication Date: 2022-01

Variant appearance in text: ERBB2: G309A

PubMed Link: 34963661

Variant Present in the following documents:

• supp_gr.275437.121_Supplementary_Table_1.xlsx, sheet 3

View BVdb publication page

---

Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology

Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C

Publication Date: 2021

Variant appearance in text: ERBB2: G309A

PubMed Link: 34630336

Variant Present in the following documents:

• Table_1.xlsx, sheet 2

View BVdb publication page

---

A Metastatic Cervical Adenocarcinoma Patient Carrying HER2 G292R Achieved Complete Response Upon Pyrotinib Treatment.

Oncotargets And Therapy

Liu, Jing J; Zhuo, Yanhong Y; Wang, Feng F; Li, Zirong Z; Lin, Yibin Y; Li, Li L; Pan, Junping J; Song, Yanwen Y; Du, Haiwei H; Li, Chanhe C; Xu, Qin Q

Publication Date: 2021

Variant appearance in text: HER2: G309A

PubMed Link: 34556997

Variant Present in the following documents:

• Main text
• ott-14-4833.pdf

View BVdb publication page

---

Dissecting the biological heterogeneity of HER2-positive breast cancer.

Breast (Edinburgh, Scotland)

Schettini, Francesco F; Prat, Aleix A

Publication Date: 2021-10

Variant appearance in text: HER2: G309A

PubMed Link: 34392185

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

---

Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer.

Cancers

Xie, Jianling J; Kusnadi, Eric P EP; Furic, Luc L; Selth, Luke A LA

Publication Date: 2021-06-29

Variant appearance in text: HER2: G309A

PubMed Link: 34209750

Variant Present in the following documents:

• Main text
• cancers-13-03254.pdf

View BVdb publication page

---

CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.

Theranostics

Shi, Zhiwen Z; Shen, Jianfeng J; Qiu, Junjun J; Zhao, Qingguo Q; Hua, Keqin K; Wang, Hongyan H

Publication Date: 2021

Variant appearance in text: ERBB2: 926G>C; G309A

PubMed Link: 34158843

Variant Present in the following documents:

• thnov11p7175s3.xlsx, sheet 1

View BVdb publication page

---

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer.

Npj Breast Cancer

Yi, Zongbi Z; Rong, Guohua G; Guan, Yanfang Y; Li, Jin J; Chang, Lianpeng L; Li, Hui H; Liu, Binliang B; Wang, Wenna W; Guan, Xiuwen X; Ouyang, Quchang Q; Li, Lixi L; Zhai, Jingtong J; Li, Chunxiao C; Li, Lifeng L; Xia, Xuefeng X; Yang, Ling L; Qian, Haili H; Yi, Xin X; Xu, Binghe B; Ma, Fei F

Publication Date: 2020

Variant appearance in text: HER2: G309A

PubMed Link: 33145402

Variant Present in the following documents:

• Main text
• 41523_2020_Article_201.pdf

View BVdb publication page

---

Usefulness of a novel device to divide core needle biopsy specimens in a spatially matched fashion.

Scientific Reports

Shiraishi, Takumi T; Inui, Shogo S; Inoue, Yuta Y; Saito, Yumiko Y; Taga, Hideto H; Kaneko, Masatomo M; Tsuji, Keisuke K; Ueda, Saya S; Ueda, Takashi T; Matsugasumi, Toru T; Taniguchi, Hidefumi H; Ueno, Akihisa A; Yamada, Takeshi T; Yamada, Yasuhiro Y; Iwata, Tsuyoshi T; Fujihara, Atsuko A; Hongo, Fumiya F; Ukimura, Osamu O

Publication Date: 2020-10-13

Variant appearance in text: rs1057519787

PubMed Link: 33051506

Variant Present in the following documents:

• 41598_2020_74136_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.

Breast Cancer Research : Bcr

Kurozumi, Sasagu S; Alsaleem, Mansour M; Monteiro, Cíntia J CJ; Bhardwaj, Kartikeya K; Joosten, Stacey E P SEP; Fujii, Takaaki T; Shirabe, Ken K; Green, Andrew R AR; Ellis, Ian O IO; Rakha, Emad A EA; Mongan, Nigel P NP; Heery, David M DM; Zwart, Wilbert W; Oesterreich, Steffi S; Johnston, Simon J SJ

Publication Date: 2020-08-11

Variant appearance in text: HER2: G309A

PubMed Link: 32782013

Variant Present in the following documents:

• Main text
• 13058_2020_Article_1324.pdf

View BVdb publication page

---

Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors.

Journal Of Translational Medicine

Li, Jiaping J; Jiang, Wei W; Wei, Jinwang J; Zhang, Jianwei J; Cai, Linbo L; Luo, Minjie M; Wang, Zhan Z; Sun, Wending W; Wang, Shengzhou S; Wang, Chen C; Dai, Chun C; Liu, Jun J; Wang, Guan G; Wang, Jiping J; Xu, Qiang Q; Deng, Yanhong Y

Publication Date: 2020-08-01

Variant appearance in text: ERBB2: G309A

PubMed Link: 32738923

Variant Present in the following documents:

• 12967_2020_2449_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Breast Cancer With a HER2 IHC2+ and FISH HER2/CEP17 Ratio ≥2.0 and an Average HER2 Gene Copy Number <4.0 per Tumor Cell: HER2 mRNA Overexpression Is a Rare Event.

Frontiers In Oncology

Liu, Yuanyuan Y; Wu, Shafei S; Shi, Xiaohua X; Mao, Feng F; Zeng, Xuan X

Publication Date: 2020

Variant appearance in text: HER2: G309A

PubMed Link: 32637359

Variant Present in the following documents:

• Main text
• fonc-10-00985.pdf

View BVdb publication page

---

mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.

Cell Reports

Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM

Publication Date: 2020-06-23

Variant appearance in text: ERBB2: G309A

PubMed Link: 32579932

Variant Present in the following documents:

• mmc5.xlsx, sheet 3

View BVdb publication page

---

Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer.

Journal Of Oncology

Gaibar, Maria M; Beltrán, Laura L; Romero-Lorca, Alicia A; Fernández-Santander, Ana A; Novillo, Apolonia A

Publication Date: 2020

Variant appearance in text: HER2: G309A

PubMed Link: 32256585

Variant Present in the following documents:

• Main text
• JO2020-6375956.pdf

View BVdb publication page

---

OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine.

Scientific Reports

López-Cortés, Andrés A; Paz-Y-Miño, César C; Guerrero, Santiago S; Cabrera-Andrade, Alejandro A; Barigye, Stephen J SJ; Munteanu, Cristian R CR; González-Díaz, Humberto H; Pazos, Alejandro A; Pérez-Castillo, Yunierkis Y; Tejera, Eduardo E

Publication Date: 2020-03-24

Variant appearance in text: ERBB2: G309A

PubMed Link: 32210335

Variant Present in the following documents:

• 41598_2020_62279_MOESM2_ESM.xlsx, sheet 33
• 41598_2020_62279_MOESM2_ESM.xlsx, sheet 40

View BVdb publication page

---

Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association

Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H

Publication Date: 2020-07

Variant appearance in text: ERBB2: G309A

PubMed Link: 32107691

Variant Present in the following documents:

• 10120_2020_1045_MOESM1_ESM.xlsx, sheet 11
• 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12

View BVdb publication page

---

Identification of an Activating Mutation in the Extracellular Domain of HER2 Conferring Resistance to Pertuzumab.

Oncotargets And Therapy

Zhang, Ying Y; Wu, Shanshan S; Zhuang, Xinlei X; Weng, Gaoqi G; Fan, Jiansheng J; Yang, Xiaoyue X; Xu, Yingchun Y; Pan, Liqiang L; Hou, Tingjun T; Zhou, Zhan Z; Chen, Shuqing S

Publication Date: 2019

Variant appearance in text: HER2: G309A

PubMed Link: 31920346

Variant Present in the following documents:

• Main text
• ott-12-11597.pdf

View BVdb publication page

---

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.

Molecular Oncology

Bertucci, François F; Rypens, Charlotte C; Finetti, Pascal P; Guille, Arnaud A; Adélaïde, José J; Monneur, Audrey A; Carbuccia, Nadine N; Garnier, Séverine S; Dirix, Piet P; Gonçalves, Anthony A; Vermeulen, Peter P; Debeb, Bisrat G BG; Wang, Xiaoping X; Dirix, Luc L; Ueno, Naoto T NT; Viens, Patrice P; Cristofanilli, Massimo M; Chaffanet, Max M; Birnbaum, Daniel D; Van Laere, Steven S

Publication Date: 2020-03

Variant appearance in text: ERBB2: G309A

PubMed Link: 31854063

Variant Present in the following documents:

• MOL2-14-504-s010.xlsx, sheet 1

View BVdb publication page

---

The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab.

Biomolecules

Shin, Jung Won JW; Kim, Soohyun S; Ha, Suji S; Choi, Byungsan B; Kim, Seongyeong S; Im, Seock-Ah SA; Yoon, Tae-Young TY; Chung, Junho J

Publication Date: 2019-10-19

Variant appearance in text: HER2: G309A

PubMed Link: 31635022

Variant Present in the following documents:

• Main text
• biomolecules-09-00629.pdf

View BVdb publication page

---

Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer.

Cancers

Collins, Denis M DM; Conlon, Neil T NT; Kannan, Srinivasaraghavan S; Verma, Chandra S CS; Eli, Lisa D LD; Lalani, Alshad S AS; Crown, John J

Publication Date: 2019-05-28

Variant appearance in text: HER2: G309A

PubMed Link: 31141894

Variant Present in the following documents:

• Main text

View BVdb publication page

---

HER2-L755S mutation induces hyperactive MAPK and PI3K-mTOR signaling, leading to resistance to HER2 tyrosine kinase inhibitor treatment.

Cell Cycle (Georgetown, Tex.)

Li, Jiayao J; Xiao, Qian Q; Bao, Yi Y; Wang, Wenyu W; Goh, Jianyuan J; Wang, Panpan P; Yu, Qiang Q

Publication Date: 2019-07

Variant appearance in text: HER2: G309A

PubMed Link: 31135266

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted Therapy.

Frontiers In Oncology

Jin, Jing J; Wu, Xu X; Yin, Jianhua J; Li, Mingxing M; Shen, Jing J; Li, Jing J; Zhao, Yueshui Y; Zhao, Qijie Q; Wu, Jingbo J; Wen, Qinglian Q; Cho, Chi Hin CH; Yi, Tao T; Xiao, Zhangang Z; Qu, Liping L

Publication Date: 2019

Variant appearance in text: HER2: G309A

PubMed Link: 31058077

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Finding driver mutations in cancer: Elucidating the role of background mutational processes.

Plos Computational Biology

Brown, Anna-Leigh AL; Li, Minghui M; Goncearenco, Alexander A; Panchenko, Anna R AR

Publication Date: 2019-04

Variant appearance in text: ERBB2: G309A

PubMed Link: 31034466

Variant Present in the following documents:

• pcbi.1006981.s010.xlsx, sheet 1

View BVdb publication page

---

Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.

Journal Of Hematology & Oncology

Lima, Zeinab Safarpour ZS; Ghadamzadeh, Mostafa M; Arashloo, Farzad Tahmasebi FT; Amjad, Ghazaleh G; Ebadi, Mohammad Reza MR; Younesi, Ladan L

Publication Date: 2019-04-11

Variant appearance in text: HER2: G309A

PubMed Link: 30975222

Variant Present in the following documents:

• Main text
• 13045_2019_Article_725.pdf

View BVdb publication page

---

Prevalence and role of HER2 mutations in cancer.

Pharmacology & Therapeutics

Cocco, Emiliano E; Lopez, Salvatore S; Santin, Alessandro D AD; Scaltriti, Maurizio M

Publication Date: 2019-07

Variant appearance in text: HER2: G309A

PubMed Link: 30951733

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Targeted mutation detection in breast cancer using MammaSeq™.

Breast Cancer Research : Bcr

Smith, Nicholas G NG; Gyanchandani, Rekha R; Shah, Osama S OS; Gurda, Grzegorz T GT; Lucas, Peter C PC; Hartmaier, Ryan J RJ; Brufsky, Adam M AM; Puhalla, Shannon S; Bahreini, Amir A; Kota, Karthik K; Wald, Abigail I AI; Nikiforov, Yuri E YE; Nikiforova, Marina N MN; Oesterreich, Steffi S; Lee, Adrian V AV

Publication Date: 2019-02-08

Variant appearance in text: ERBB2: G309A

PubMed Link: 30736836

Variant Present in the following documents:

• 13058_2019_1102_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Meric-Bernstam, Funda F; Johnson, Amber M AM; Dumbrava, Ecaterina E Ileana EEI; Raghav, Kanwal K; Balaji, Kavitha K; Bhatt, Michelle M; Murthy, Rashmi K RK; Rodon, Jordi J; Piha-Paul, Sarina A SA

Publication Date: 2019-04-01

Variant appearance in text: HER2: G309A

PubMed Link: 30442682

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Croessmann, Sarah S; Formisano, Luigi L; Kinch, Lisa N LN; Gonzalez-Ericsson, Paula I PI; Sudhan, Dhivya R DR; Nagy, Rebecca J RJ; Mathew, Aju A; Bernicker, Eric H EH; Cristofanilli, Massimo M; He, Jie J; Cutler, Richard E RE; Lalani, Alshad S AS; Miller, Vincent A VA; Lanman, Richard B RB; Grishin, Nick V NV; Arteaga, Carlos L CL

Publication Date: 2019-01-01

Variant appearance in text: ERBB2: G309A

PubMed Link: 30314968

Variant Present in the following documents:

• Main text

View BVdb publication page

---

The prognostic effects of somatic mutations in ER-positive breast cancer.

Nature Communications

Griffith, Obi L OL; Spies, Nicholas C NC; Anurag, Meenakshi M; Griffith, Malachi M; Luo, Jingqin J; Tu, Dongsheng D; Yeo, Belinda B; Kunisaki, Jason J; Miller, Christopher A CA; Krysiak, Kilannin K; Hundal, Jasreet J; Ainscough, Benjamin J BJ; Skidmore, Zachary L ZL; Campbell, Katie K; Kumar, Runjun R; Fronick, Catrina C; Cook, Lisa L; Snider, Jacqueline E JE; Davies, Sherri S; Kavuri, Shyam M SM; Chang, Eric C EC; Magrini, Vincent V; Larson, David E DE; Fulton, Robert S RS; Liu, Shuzhen S; Leung, Samuel S; Voduc, David D; Bose, Ron R; Dowsett, Mitch M; Wilson, Richard K RK; Nielsen, Torsten O TO; Mardis, Elaine R ER; Ellis, Matthew J MJ

Publication Date: 2018-09-04

Variant appearance in text: ERBB2: G309A

PubMed Link: 30181556

Variant Present in the following documents:

• 41467_2018_5914_MOESM4_ESM.xlsx, sheet 1

View BVdb publication page

---

Biotinylated amplicon sequencing: A method for preserving DNA samples of limited quantity.

Practical Laboratory Medicine

Cravero, Karen K; Medford, Arielle A; Pallavajjala, Aparna A; Canzoniero, Jenna J; Hunter, Natasha N; Chu, David D; Cochran, Rory L RL; Waters, Ian I; Christenson, Eric S ES; Kyker-Snowman, Kelly K; Button, Berry B; Cole, Alex J AJ; Park, Ben Ho BH

Publication Date: 2018-11

Variant appearance in text: HER2: G309A

PubMed Link: 30140723

Variant Present in the following documents:

• mmc1.pdf

View BVdb publication page

---

Integrative omics analyses broaden treatment targets in human cancer.

Genome Medicine

Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyö, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L

Publication Date: 2018-07-27

Variant appearance in text: ERBB2: G309A

PubMed Link: 30053901

Variant Present in the following documents:

• 13073_2018_564_MOESM2_ESM.xlsx, sheet 19
• 13073_2018_564_MOESM2_ESM.xlsx, sheet 10
• 13073_2018_564_MOESM2_ESM.xlsx, sheet 8
• 13073_2018_564_MOESM2_ESM.xlsx, sheet 3
• 13073_2018_564_MOESM2_ESM.xlsx, sheet 2

View BVdb publication page

---

Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)

Chen, Yinnan Y; Zhang, Yanmin Y

Publication Date: 2018-06

Variant appearance in text: HER2: G309A

PubMed Link: 29938175

Variant Present in the following documents:

• Main text
• ADVS-5-1700964.pdf

View BVdb publication page

---

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.

Cell Reports

Way, Gregory P GP; Sanchez-Vega, Francisco F; La, Konnor K; Armenia, Joshua J; Chatila, Walid K WK; Luna, Augustin A; Sander, Chris C; Cherniack, Andrew D AD; Mina, Marco M; Ciriello, Giovanni G; Schultz, Nikolaus N; , ; Sanchez, Yolanda Y; Greene, Casey S CS

Publication Date: 2018-04-03

Variant appearance in text: ERBB2: Gly309Ala

PubMed Link: 29617658

Variant Present in the following documents:

• NIHMS958974-supplement-6.xlsx, sheet 1

View BVdb publication page

---

HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors.

Breast Cancer Research : Bcr

Daemen, Anneleen A; Manning, Gerard G

Publication Date: 2018-01-30

Variant appearance in text: HER2: G309A

PubMed Link: 29382369

Variant Present in the following documents:

• Main text
• 13058_2018_933_MOESM11_ESM.pdf
• 13058_2018_Article_933.pdf

View BVdb publication page

---

Genomic alterations of ERBB receptors in cancer: clinical implications.

Oncotarget

Mishra, Rosalin R; Hanker, Ariella B AB; Garrett, Joan T JT

Publication Date: 2017-12-26

Variant appearance in text: HER2: G309A

PubMed Link: 29371993

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Prevalence and detection of low-allele-fraction variants in clinical cancer samples.

Nature Communications

Shin, Hyun-Tae HT; Choi, Yoon-La YL; Yun, Jae Won JW; Kim, Nayoung K D NKD; Kim, Sook-Young SY; Jeon, Hyo Jeong HJ; Nam, Jae-Yong JY; Lee, Chung C; Ryu, Daeun D; Kim, Sang Cheol SC; Park, Kyunghee K; Lee, Eunjin E; Bae, Joon Seol JS; Son, Dae Soon DS; Joung, Je-Gun JG; Lee, Jeeyun J; Kim, Seung Tae ST; Ahn, Myung-Ju MJ; Lee, Se-Hoon SH; Ahn, Jin Seok JS; Lee, Woo Yong WY; Oh, Bo Young BY; Park, Yeon Hee YH; Lee, Jeong Eon JE; Lee, Kwang Hyuk KH; Kim, Hee Cheol HC; Kim, Kyoung-Mee KM; Im, Young-Hyuck YH; Park, Keunchil K; Park, Peter J PJ; Park, Woong-Yang WY

Publication Date: 2017-11-09

Variant appearance in text: ERBB2: G309A

PubMed Link: 29123093

Variant Present in the following documents:

• 41467_2017_1470_MOESM11_ESM.xlsx, sheet 1

View BVdb publication page

---

Genomic Evolution of Breast Cancer Metastasis and Relapse.

Cancer Cell

Yates, Lucy R LR; Knappskog, Stian S; Wedge, David D; Farmery, James H R JHR; Gonzalez, Santiago S; Martincorena, Inigo I; Alexandrov, Ludmil B LB; Van Loo, Peter P; Haugland, Hans Kristian HK; Lilleng, Peer Kaare PK; Gundem, Gunes G; Gerstung, Moritz M; Pappaemmanuil, Elli E; Gazinska, Patrycja P; Bhosle, Shriram G SG; Jones, David D; Raine, Keiran K; Mudie, Laura L; Latimer, Calli C; Sawyer, Elinor E; Desmedt, Christine C; Sotiriou, Christos C; Stratton, Michael R MR; Sieuwerts, Anieta M AM; Lynch, Andy G AG; Martens, John W JW; Richardson, Andrea L AL; Tutt, Andrew A; Lønning, Per Eystein PE; Campbell, Peter J PJ

Publication Date: 2017-08-14

Variant appearance in text: ERBB2: G309A

PubMed Link: 28810143

Variant Present in the following documents:

• mmc4.xlsx, sheet 4

View BVdb publication page

---

CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases.

Oncotarget

Khan, Faheem Ahmed FA; Pandupuspitasari, Nuruliarizki Shinta NS; Chun-Jie, Huang H; Ao, Zhou Z; Jamal, Muhammad M; Zohaib, Ali A; Khan, Farhan Ahmed FA; Hakim, Muthia Raihana MR; ShuJun, Zhang Z

Publication Date: 2016-08-09

Variant appearance in text: HER2: G309A

PubMed Link: 27250031

Variant Present in the following documents:

• oncotarget-07-52541.pdf

View BVdb publication page

---

Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology.

Oncotarget

Ibarrola-Villava, Maider M; Fleitas, Tania T; Llorca-Cardeñosa, Marta J MJ; Mongort, Cristina C; Alonso, Elisa E; Navarro, Samuel S; Burgues, Octavio O; Vivancos, Ana A; Cejalvo, Juan Miguel JM; Perez-Fidalgo, José Alejandro JA; Roselló, Susana S; Ribas, Gloria G; Cervantes, Andrés A

Publication Date: 2016-04-19

Variant appearance in text: ERBB2: G309A

PubMed Link: 26968814

Variant Present in the following documents:

• oncotarget-07-22543-s001.pdf

View BVdb publication page

---

Functional annotation of rare gene aberration drivers of pancreatic cancer.

Nature Communications

Tsang, Yiu Huen YH; Dogruluk, Turgut T; Tedeschi, Philip M PM; Wardwell-Ozgo, Joanna J; Lu, Hengyu H; Espitia, Maribel M; Nair, Nikitha N; Minelli, Rosalba R; Chong, Zechen Z; Chen, Fengju F; Chang, Qing Edward QE; Dennison, Jennifer B JB; Dogruluk, Armel A; Li, Min M; Ying, Haoqiang H; Bertino, Joseph R JR; Gingras, Marie-Claude MC; Ittmann, Michael M; Kerrigan, John J; Chen, Ken K; Creighton, Chad J CJ; Eterovic, Karina K; Mills, Gordon B GB; Scott, Kenneth L KL

Publication Date: 2016-01-25

Variant appearance in text: ERBB2: G309A

PubMed Link: 26806015

Variant Present in the following documents:

• ncomms10500-s2.xls, sheet 1

View BVdb publication page

---

HER2 missense mutations have distinct effects on oncogenic signaling and migration.

Proceedings Of The National Academy Of Sciences Of The United States Of America

Zabransky, Daniel J DJ; Yankaskas, Christopher L CL; Cochran, Rory L RL; Wong, Hong Yuen HY; Croessmann, Sarah S; Chu, David D; Kavuri, Shyam M SM; Red Brewer, Monica M; Rosen, D Marc DM; Dalton, W Brian WB; Cimino-Mathews, Ashley A; Cravero, Karen K; Button, Berry B; Kyker-Snowman, Kelly K; Cidado, Justin J; Erlanger, Bracha B; Parsons, Heather A HA; Manto, Kristen M KM; Bose, Ron R; Lauring, Josh J; Arteaga, Carlos L CL; Konstantopoulos, Konstantinos K; Park, Ben Ho BH

Publication Date: 2015-11-10

Variant appearance in text: HER2: G309A

PubMed Link: 26508629

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Analysis of different HER-2 mutations in breast cancer progression and drug resistance.

Journal Of Cellular And Molecular Medicine

Sun, Zijia Z; Shi, Yaqin Y; Shen, Yan Y; Cao, Lulu L; Zhang, Wenwen W; Guan, Xiaoxiang X

Publication Date: 2015-12

Variant appearance in text: HER-2: G309A

PubMed Link: 26305917

Variant Present in the following documents:

• Main text
• JCMM-19-2691.pdf

View BVdb publication page

---